Diagnosis and therapy of cognitive impairment in chronic cerebral ischemia
Open Access
- 12 April 2025
- journal article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 3,p. 71-80
Abstract
Chronic cerebral ischemia is a common condition associated with progressive brain damage that manifests itself in various neurological disorders, including cognitive impairment. One of the etiologic factors of vascular disorders is arterial hypertension. The article discusses types of cognitive impairment and pathogenetic mechanisms of their formation. The role of the glymphatic system of the brain, the role of neuroinflammation in the implementation of cognitive impairment are discussed. The described clinical case shows the need to supplement basic therapy in patients with hypertension with drugs of other groups, in particular pentoxifylline, to improve the effectiveness of therapy. The article reviews the latest clinical and experimental studies of pentoxifylline, which show its positive effect on inflammation, endothelial dysfunction and, as a result, improvement of cognitive functions. The neuroprotective effect of pentoxifylline, which has been confirmed in experimental and clinical studies, is discussed. The possibility of using pentoxifylline in patients with mood disorders, major depressive disorder, bipolar disorder as an adjunct to the main therapy, and in cognitive impairment as monotherapy is discussed.Keywords
This publication has 63 references indexed in Scilit:
- Effects of the anti-inflammatory pentoxifylline on psychiatric and neuropsychiatric conditions: exploring various off-label utilities with meta-analysesInflammopharmacology, 2025
- Pentoxifylline protects memory performance in streptozotocin-induced diabetic ratsBrain Research, 2024
- Therapeutic effects of pentoxifylline in propionic acid‐induced autism symptoms in rat models: A behavioral, biochemical, and histopathological studyInternational Journal of Developmental Neuroscience, 2024
- Efficacy of pentoxifylline for the treatment of bipolar I/II patients with treatment-resistant depression: A proof-of-concept, randomized, double-blind, placebo-controlled trialBrain Research Bulletin, 2024
- Pentoxifylline as Add-On Treatment to Donepezil in Copper Sulphate-Induced Alzheimer’s Disease-Like Neurodegeneration in RatsNeurotoxicity Research, 2023
- Executive functions2019
- Pentoxifylline prevents post-traumatic stress disorder induced memory impairmentBrain Research Bulletin, 2018
- Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) CohortJAMA Neurology, 2017
- Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapyActa Neuropathologica, 2009
- Subcortical vascular dementiaGeriatric Nursing, 2005